144 related articles for article (PubMed ID: 14596612)
1. Interaction of neuropeptide Y and Hsp90 through a novel peptide binding region.
Ishiwatari-Hayasaka H; Maruya M; Sreedhar AS; Nemoto TK; Csermely P; Yahara I
Biochemistry; 2003 Nov; 42(44):12972-80. PubMed ID: 14596612
[TBL] [Abstract][Full Text] [Related]
2. Strongly altered receptor binding properties in PP and NPY chimeras are accompanied by changes in structure and membrane binding.
Lerch M; Kamimori H; Folkers G; Aguilar MI; Beck-Sickinger AG; Zerbe O
Biochemistry; 2005 Jun; 44(25):9255-64. PubMed ID: 15966750
[TBL] [Abstract][Full Text] [Related]
3. Structure and dynamics of micelle-bound neuropeptide Y: comparison with unligated NPY and implications for receptor selection.
Bader R; Bettio A; Beck-Sickinger AG; Zerbe O
J Mol Biol; 2001 Jan; 305(2):307-29. PubMed ID: 11124908
[TBL] [Abstract][Full Text] [Related]
4. Studies of the structure of the N-terminal domain from the Y4 receptor - a G protein-coupled receptor - and its interaction with hormones from the NPY family.
Zou C; Kumaran S; Markovic S; Walser R; Zerbe O
Chembiochem; 2008 Sep; 9(14):2276-84. PubMed ID: 18767100
[TBL] [Abstract][Full Text] [Related]
5. An unstructured C-terminal region of the Hsp90 co-chaperone p23 is important for its chaperone function.
Weikl T; Abelmann K; Buchner J
J Mol Biol; 1999 Oct; 293(3):685-91. PubMed ID: 10543959
[TBL] [Abstract][Full Text] [Related]
6. Hsp90 is a direct target of the anti-allergic drugs disodium cromoglycate and amlexanox.
Okada M; Itoh H; Hatakeyama T; Tokumitsu H; Kobayashi R
Biochem J; 2003 Sep; 374(Pt 2):433-41. PubMed ID: 12803546
[TBL] [Abstract][Full Text] [Related]
7. Structural studies on the co-chaperone Hop and its complexes with Hsp90.
Onuoha SC; Coulstock ET; Grossmann JG; Jackson SE
J Mol Biol; 2008 Jun; 379(4):732-44. PubMed ID: 18485364
[TBL] [Abstract][Full Text] [Related]
8. Structure of prejunctional receptor binding analog of human neuropeptide Y dimer ANA-NPY.
Barden JA
Biochem Biophys Res Commun; 1995 Oct; 215(1):264-71. PubMed ID: 7575600
[TBL] [Abstract][Full Text] [Related]
9. The region adjacent to the highly immunogenic site and shielded by the middle domain is responsible for self-oligomerization/client binding of the HSP90 molecular chaperone.
Nemoto TK; Fukuma Y; Yamada S; Kobayakawa T; Ono T; Ohara-Nemoto Y
Biochemistry; 2004 Jun; 43(23):7628-36. PubMed ID: 15182205
[TBL] [Abstract][Full Text] [Related]
10. The contribution of helical potential to the in vitro receptor binding activity of a neuropeptide Y N-terminal deletion fragment.
Doughty MB; Hu L
Biopolymers; 1993 Aug; 33(8):1195-206. PubMed ID: 8364154
[TBL] [Abstract][Full Text] [Related]
11. Structural similarities of micelle-bound peptide YY (PYY) and neuropeptide Y (NPY) are related to their affinity profiles at the Y receptors.
Lerch M; Mayrhofer M; Zerbe O
J Mol Biol; 2004 Jun; 339(5):1153-68. PubMed ID: 15178255
[TBL] [Abstract][Full Text] [Related]
12. Stabilization of alpha-helix in C-terminal fragments of neuropeptide Y.
Yumoto N; Murase S; Hattori T; Yamamoto H; Tatsu Y; Yoshikawa S
Biochem Biophys Res Commun; 1993 Nov; 196(3):1490-5. PubMed ID: 8250906
[TBL] [Abstract][Full Text] [Related]
13. Domain-mediated dimerization of the Hsp90 cochaperones Harc and Cdc37.
Roiniotis J; Masendycz P; Ho S; Scholz GM
Biochemistry; 2005 May; 44(17):6662-9. PubMed ID: 15850399
[TBL] [Abstract][Full Text] [Related]
14. A novel chaperone-activity-reducing mechanism of the 90-kDa molecular chaperone HSP90.
Itoh H; Ogura M; Komatsuda A; Wakui H; Miura AB; Tashima Y
Biochem J; 1999 Nov; 343 Pt 3(Pt 3):697-703. PubMed ID: 10527951
[TBL] [Abstract][Full Text] [Related]
15. The crystal structure of the carboxy-terminal dimerization domain of htpG, the Escherichia coli Hsp90, reveals a potential substrate binding site.
Harris SF; Shiau AK; Agard DA
Structure; 2004 Jun; 12(6):1087-97. PubMed ID: 15274928
[TBL] [Abstract][Full Text] [Related]
16. Effects of covalent dimerization on the structure and function of the carboxy-terminal fragment of neuropeptide Y.
Uegaki K; Murase S; Nemoto N; Kobayashi Y; Yoshikawa S; Yumoto N
Biochem Biophys Res Commun; 1997 Dec; 241(3):737-43. PubMed ID: 9434778
[TBL] [Abstract][Full Text] [Related]
17. A client-binding site of Cdc37.
Terasawa K; Minami Y
FEBS J; 2005 Sep; 272(18):4684-90. PubMed ID: 16156789
[TBL] [Abstract][Full Text] [Related]
18. MUC1 oncoprotein is targeted to mitochondria by heregulin-induced activation of c-Src and the molecular chaperone HSP90.
Ren J; Bharti A; Raina D; Chen W; Ahmad R; Kufe D
Oncogene; 2006 Jan; 25(1):20-31. PubMed ID: 16158055
[TBL] [Abstract][Full Text] [Related]
19. HSP90, HSP70, and GAPDH directly interact with the cytoplasmic domain of macrophage scavenger receptors.
Nakamura T; Hinagata J; Tanaka T; Imanishi T; Wada Y; Kodama T; Doi T
Biochem Biophys Res Commun; 2002 Jan; 290(2):858-64. PubMed ID: 11785981
[TBL] [Abstract][Full Text] [Related]
20. HBV polymerase interacts independently with N-terminal and C-terminal fragments of Hsp90beta.
Cho G; Suh SW; Jung G
Biochem Biophys Res Commun; 2000 Jul; 274(1):203-11. PubMed ID: 10903919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
